The increased levels of ROS most likely must be considered an indicator of a more differentiated AML cell population with reduced stem cell potential rather than a direct consequence of active IL-21 signaling, as underscored by our main finding that IL-21 signaling reduces the amount of functional LSCs. Here, IL21 is linked to acute myeloid leukemia.